NCT03717402View on ClinicalTrials.gov

Smartphone Technology to Alleviate Malignant Pain (STAMP)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
CancerPain ManagementOpioid Use
Interventions
BEHAVIORAL

Intervention Participants

Patients with advances cancer using opioids for chronic pain will be enrolled and asked to use the STAMP cancer pain management app for 4 weeks.

Trial Locations (1)

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT03717402 - Smartphone Technology to Alleviate Malignant Pain (STAMP) | Biotech Hunter | Biotech Hunter